Search
Search Constraints
You searched for: Author/Creator Sapra, Puja- Sapra, Puja [remove] 5
- 616.0798 2
- Antibodies, Monoclonal -- Periodicals 2
- Monoclonal antibodies -- Periodicals 2
- Monoclonal antibodies -- Therapeutic use -- Periodicals 2
- 571.96 1
- 610 1
- 615.105 1
- Ab antibody -- ADC antibody–drug conjugate -- ADCC antibody-dependent cell-mediated cytotoxicity -- AE adverse event -- ALL acute lymphoblastic leukemia -- AUC the area under the plasma concentration time curve -- AUCtau area under the curve extrapolated over the dosage interval -- B-ALL acute B-cell lymphoblastic leukemia -- BCP-ALL B-cell precursor ALL -- calicheamicin-DMH N-acetyl-γ-calicheamicin dimethylhydrizide -- CDC complement-dependent cytotoxicity -- CHOP cyclophosphamide, doxorubicin, vincristine, and prednisone -- CLL chronic lymphocytic leukemia -- CR complete response -- DLBCL diffuse large B-cell lymphoma -- DLT dose-limiting toxicity -- FL follicular lymphoma -- GO gemtuzumab ozogamicin -- HCL hairy cell leukemia -- HL Hodgkin lymphoma -- IgG immunoglobulin G -- IgM immunoglobulin M -- IgD immunoglobulin D -- ITIMs immunoreceptor tyrosine-based inhibitory motifs -- IV intravenous -- IP intraperitoneal -- mAb monoclonal antibody -- MCL mantle cell lymphoma -- MED minimum efficacious dose -- MZL marginal zone lymphoma -- MRD minimal residual disease -- MTD maximal tolerated dose -- NHL non-Hodgkin's lymphoma -- ORR overall response rate (ORR) -- PFS progression-free survival -- PK pharmacokinetics -- PR partial response -- qw weekly schedule -- q2w every two weeks -- q3w every three weeks -- q4w every four weeks -- q4dx2 every fourth day for a total of two injections -- q4dx3 every fourth day for a total of three injections -- r/r relapsed/refractory -- SCID severe combined immunodeficiency -- SCT stem cell transplantation -- VOD veno-occlusive disease 1
- Allergy and Immunology -- Periodicals 1
- Antibody drug conjugate -- Hematologic malignancies -- Cytotoxic compounds -- Pharmacology -- DNA damaging agents -- Non-Hodgkin's lymphoma 1